Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

U.S. Physical Therapy (NY: USPH )

105.20 +1.56 (+1.51%)
Official Closing Price Updated: 7:00 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,646
Open 104.75
Bid (Size) 102.48 (5)
Ask (Size) 108.00 (1)
Prev. Close 103.64
Today's Range 103.65 - 105.20
52wk Range 78.08 - 124.11
Shares Outstanding 13,004,245
Dividend Yield 1.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
U.S. Physical Therapy Announces Acquisitions
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call
From U.S. Physical Therapy, Inc.
Via Business Wire

Performance

YTD
+12.55%
+12.55%
1 Month
-1.87%
-1.87%
3 Month
+11.19%
+11.19%
6 Month
+26.23%
+26.23%
1 Year
-1.11%
-1.11%

More News

Read More
U.S. Physical Therapy Announces Acquisition of a Nine-Clinic Physical Therapy And Hand Therapy Practice
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy Announces Change in Medicare Rate Reduction for the Remainder of 2024
From U.S. Physical Therapy, Inc.
Via Business Wire
US Physical Therapy's Ex-Dividend Date Is Monday, Here's What You Need To Know
Via Benzinga
U.S. Physical Therapy to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy Reports Fourth Quarter and Full Year 2023 Results
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year End 2023 Earnings Release and Conference Call Dates
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From U.S. Physical Therapy, Inc.
Via Business Wire
US Physical Therapy's Ex-Dividend Date Is Thursday, Here's What You Need To Know
Via Benzinga
Earnings Scheduled For February 28, 2024
Via Benzinga
Barrington Research Maintains Outperform Rating for US Physical Therapy: Here's What You Need To Know
Via Benzinga
7 Dividend-Paying Healthcare Stocks for Income Investors
Via InvestorPlace
Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio
Via InvestorPlace
U.S. Physical Therapy to Present at the Stephens Annual Investment Conference and the 15th Annual Southwest IDEAS Investor Conference
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy Reports Third Quarter 2023 Results
From U.S. Physical Therapy, Inc.
Via Business Wire
Earnings Scheduled For November 7, 2023
Via Benzinga
U.S. Physical Therapy Announces Acquisition of an Industrial Injury Prevention Services and Ergonomics Software Business
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call Date
From U.S. Physical Therapy
Via Business Wire
U.S. Physical Therapy Announces Acquisition of Two Physical Therapy Practices
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy to Present at the 2023 Midwest IDEAS Investor Conference
From U.S. Physical Therapy, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Via Benzinga
U.S. Physical Therapy Reports Second Quarter 2023 Results
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy Announces Acquisition of a Five-Clinic Physical Therapy Practice
From U.S. Physical Therapy, Inc.
Via Business Wire
U.S. Physical Therapy, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call Dates
From U.S. Physical Therapy, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.